Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML

Clinical trial NCT05471323 · UNKNOWN

Trial details

NCT number: NCT05471323
Sponsor: Guangdong Ruishun Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2021-01-14
Primary completion: 2023-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.